Skip to content
AnalystLens
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 6-K filed June 21, 2024. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc filed this Form 6-K on 21 June 2024 with a set of ASX-required notices and attachments.

The bulk of the filing is routine: daily on-market buy-back notifications, Appendix 2A share quotation notices for shares issued under employee and director plans, Appendix 3Y director interest notices, and a substantial holding notice. The buy-back notices show cumulative shares bought back before the previous day of 6,617,403 and 12,600 bought back on 20 June 2024, for total consideration of AUD 340,312,424.22 and AUD 601,380.60 respectively. The notices state a maximum of 8,276,390 shares that may be bought back, with 1,646,387 remaining as at the end of 20 June 2024, and a buy-back period running from 13 November 2023 to 31 October 2024.

Other notices report that Challenger Limited, through Fidante Partners Limited, increased its aggregated interest in the company to 4.0019%a of ordinary share capital from 3.9071% following a change on 13 June 2024. Eight non-executive directors received American Depositary Receipts or CUFS under the James Hardie 2020 Non-Executive Director Equity Plan on 14 June 2024. The company also disclosed the timing of its 2024 Annual General Meeting, which is scheduled for 8 August 2024 (Dublin time), with director nomination requests due by 27 June 2024.

The filing also includes the company's FY2024 Annual Report, which reports record results: Global Net Sales of US$3,936.3 millionb (up 4% from FY23), Global Adjusted EBIT of US$940.8 million (up 21%), Global Adjusted Net Income of US$707.5 million (up 17%), and adjusted ROCE of 55%. Management highlights include the appointment of Rachel Wilson as Chief Financial Officer and the addition of John Pfeifer to the Board. The filing's forward-looking statements caution that results may differ materially from expectations, citing risks such as asbestos-related obligations, tax matters, competition, and housing market conditions.

Key Highlights

  1. FY2024 results in the Annual Report (Exhibit 99.18) show record Global Net Sales of US$3,936.3 million, up 4% from FY23, and Global Adjusted EBIT of US$940.8 million, up 21%.
  2. Global Adjusted Net Income was US$707.5 million, up 17% from FY23, and adjusted ROCE was 55% for FY24, averaging 45% over the last five years per the shareholder letter.
  3. Ongoing on-market buy-back: 6,617,403 shares bought back before 20 June 2024 plus 12,600 on 20 June, with a maximum of 8,276,390 shares and 1,646,387 remaining as at 20 June 2024.
  4. Challenger Limited (via Fidante Partners Limited) reported an aggregated interest of 4.0019% of ordinary share capital, up from 3.9071%, following a change on 13 June 2024.
  5. Eight non-executive directors received ADRs or CUFS on 14 June 2024 under the 2020 Non-Executive Director Equity Plan, as disclosed in Appendix 3Y notices.
  6. The 2024 Annual General Meeting is scheduled for 8 August 2024, with director nomination requests due by 27 June 2024.
  7. Management changes noted in the Annual Report include new Chief Financial Officer Rachel Wilson and new Board member John Pfeifer.

Frequently Asked Questions

  1. How much stock is the company buying back under its current program?

    The buy-back notices state a maximum of 8,276,390 ordinary shares/CUFS, with a proposed buy-back period from 13 November 2023 to 31 October 2024. As at the end of 20 June 2024, 1,646,387 shares remained to be bought back. Cumulative shares bought back before 20 June 2024 totalled 6,617,403, with 12,600 bought on 20 June, for total consideration of AUD 340,312,424.22 before that day and AUD 601,380.60 on that day.

  2. How did James Hardie perform in fiscal 2024?

    The FY2024 Annual Report describes record results, with Global Net Sales of US$3,936.3 million (up 4%), Global Adjusted EBIT of US$940.8 million (up 21%), and Global Adjusted Net Income of US$707.5 million (up 17%). Adjusted ROCE was 55% for FY24. North America Net Sales were US$2,891.4 million, up 4%, with EBIT of US$921.1 million, up 20%.

  3. Did any major shareholder change its holding?

    Yes. A substantial holding notice dated 17 June 2024 from Challenger Limited, on behalf of Fidante Partners Limited, reports an aggregated interest of 4.0019% of ordinary share capital, up from 3.9071%, following a change on 13 June 2024.

  4. When is the next Annual General Meeting and what is the deadline for director nominations?

    The 2024 Annual General Meeting will be held on Thursday, 8 August 2024 at 10:00pm Dublin time (Friday, 9 August 2024 at 7:00am Sydney time), at the company's Dublin headquarters and simultaneously by teleconference. The closing date for receipt of director nominations is Thursday, 27 June 2024.